| Ident. | Authors (with country if any) | Title |
|---|
| 000144 (2014) |
Zanfina Ademi [Australie] ; Danny Liew [Australie] ; Alexandra Gorelik [Australie] ; Megan Bohensky [Australie] ; Ella Zomer [Australie] ; Bruce Hollingsworth [Royaume-Uni] ; Gabriel Steg [France] ; Deepak L. Bhatt [États-Unis] ; Christopher M. Reid [Australie] | Predictors of health care use among patients with or at high risk of atherothrombotic disease: Two-year follow-up data |
| 000393 (2014) |
Pierre Amarenco [France] ; Stephen Davis [Australie] ; Elizabeth F. Jones [Australie] ; Ariel A. Cohen [France] ; Wolf-Dieter Heiss [Allemagne] ; Markku Kaste [Finlande] ; Cédric Laouenan [France] ; Dennis Young [Australie] ; Malcolm Macleod [Australie, Royaume-Uni] ; Geoffrey A. Donnan [Australie] | Clopidogrel Plus Aspirin Versus Warfarin in Patients With Stroke and Aortic Arch Plaques |
| 000533 (2013) |
Robert S. Rosenson [États-Unis] ; H. Bryan Jr Brewer [États-Unis] ; Benjamin Ansell [États-Unis] ; Philip Barter [Australie] ; M. John Chapman [France] ; Jay W. Heinecke [États-Unis] ; Anatol Kontush [France] ; Alan R. Tall [États-Unis] ; Nancy R. Webb [États-Unis] | Translation of High-Density Lipoprotein Function Into Clinical Practice: Current Prospects and Future Challenges |
| 000582 (2013) |
Zanfina Ademi [Australie] ; Molla M. Huq [Australie] ; Danny Liew [Australie] ; Ph. Gabriel Steg [France] ; Deepak L. Bhatt [États-Unis] ; Mark Nelson [Australie] ; Christopher M. Reid [Australie] | The Impact of Lost Therapeutic Benefit (LTB) in High-Risk Hypertensive Patients: 2-Year Follow-Up Data from the Australian REACH Registry |
| 000604 (2013) |
Elisabeth Lambert [Australie] ; Yves D'Udekem [Australie] ; Michael Cheung [Australie] ; Carolina Ika Sari [Australie] ; Julia Inman [Australie] ; Anna Ahimastos [Australie] ; Nina Eikelis [Australie] ; Atul Pathak [France] ; Ingrid King [Australie] ; Leanne Grigg [Australie] ; Markus Schlaich [Australie] ; Gavin Lambert [Australie] | Sympathetic and vascular dysfunction in adult patients with Fontan circulation |
| 000699 (2013) |
Arjan J. Kwakernaak [Pays-Bas] ; Gilles Lambert [Australie, France] ; Maartje C. J. Slagman [Pays-Bas] ; Femke Waanders [Pays-Bas] ; Gozewijn D. Laverman [Pays-Bas] ; Francine Petrides [Australie] ; Bert D. Dikkeschei [Pays-Bas] ; Gerjan Navis [Pays-Bas] ; Robin P. F. Dullaart [Pays-Bas] | Proprotein convertase subtilisin-kexin type 9 is elevated in proteinuric subjects: Relationship with lipoprotein response to antiproteinuric treatment |
| 000933 (2013) |
Matthieu Plichart [France] ; Frederique Thomas [France] ; Jean-Philippe Empana [France] ; Kathryn Bean [France] ; Marie-Cécile Perier [France] ; David S. Celermajer [Australie] ; Olivier Hanon [France] ; Nicolas Danchin [France] ; Bruno Pannier [France] ; Xavier Jouven [France] | Gender-specific trends in heart rate in the general population from 1992-2007: a study of 226,288 French adults |
| 000934 (2013) |
Bronwyn A. Kingwell [Australie] ; M. John Chapman [France] | Future of High-Density Lipoprotein Infusion Therapies: Potential for Clinical Management of Vascular Disease |
| 000A27 (2013) |
Frédéric Dutheil [France, Australie] ; Gérard Lac [France] ; Bruno Lesourd [France] ; Robert Chapier [France] ; Guillaume Walther [France] ; Agnès Vinet [France] ; Vincent Sapin [France] ; Julien Verney [France] ; Lemlih Ouchchane [France] ; Martine Duclos [France] ; Philippe Obert [Australie, France] ; Daniel Courteix [France, Australie] | Different modalities of exercise to reduce visceral fat mass and cardiovascular risk in metabolic syndrome: the RESOLVE* randomized trial |
| 000A76 (2013) |
Rishi Puri [États-Unis] ; Steven E. Nissen [États-Unis] ; Peter Libby [États-Unis] ; Mingyuan Shao [États-Unis] ; Christie M. Ballantyne [États-Unis] ; Phillip J. Barter [Australie] ; M. John Chapman [France] ; Raimund Erbel [Allemagne] ; Joel S. Raichlen [Australie] ; Kiyoko Uno [États-Unis] ; Yu Kataoka [États-Unis] ; Stephen J. Nicholls [États-Unis, Australie] | C-Reactive Protein, but not Low-Density Lipoprotein Cholesterol Levels, Associate With Coronary Atheroma Regression and Cardiovascular Events After Maximally Intensive Statin Therapy |
| 000E79 (2012) |
Christopher M. Reid [Australie] ; Zanfina Ademi [Australie] ; Mark R. Nelson [Australie] ; Greg Connor [Australie] ; Derek P. Chew [Australie] ; Louise Shiel [Australie] ; Ana Smeath [Australie] ; Fred De Looze [Australie] ; Ph Gabriel Steg [France] ; Deepak L. Bhatt [États-Unis] ; Danny Liew [Australie] | Outcomes from the REACH Registry for Australian general practice patients with or at high risk of atherothrombosis |
| 001010 (2012) |
Priscila Ramos-Mozo [Espagne] ; Julio Madrigal-Matute [Espagne] ; Melina Vega De Ceniga [Espagne] ; Luis Miguel Blanco-Colio [Espagne] ; Olivier Meilhac [France] ; Laurent Feldman [France] ; Jean-Baptiste Michel [France] ; Paula Clancy [Australie] ; Jonathan Golledge [Australie] ; Paul E. Norman [Australie] ; Jesus Egido [Australie] ; Jose Luis Martin-Ventura [Espagne] | Increased plasma levels of NGAL, a marker of neutrophil activation, in patients with abdominal aortic aneurysm |
| 001326 (2012) |
Andrew I. U. Shearn [France] ; Virginie Deswaerte [France, Australie] ; Emmanuel L. Gautier [France] ; Flora Saint-Charles [France] ; John Pirault [France] ; Laura Bouchareychas [France] ; Edmund B. Iii Rucker [France] ; Sophie Beliard [France] ; John Chapman [France] ; Wendy Jessup [Australie] ; Thierry Huby [France] ; Philippe Lesnik [France] | Bcl-x Inactivation in Macrophages Accelerates Progression of Advanced Atherosclerotic Lesions in Apoe-/- Mice |
| 001520 (2011) |
M. John Chapman [France] ; Henry N. Ginsberg [États-Unis] ; Pierre Amarenco [France] ; Felicita Andreotti [Italie] ; Jan Boren [Suède] ; Alberico L. Catapano [Italie] ; Olivier S. Descamps [Belgique] ; Edward Fisher [États-Unis] ; Petri T. Kovanen [Finlande] ; Jan Albert Kuivenhoven [Pays-Bas] ; Philippe Lesnik [France] ; Luis Masana [Espagne] ; Borge G. Nordestgaard [Danemark] ; Kausik K. Ray [Royaume-Uni] ; Zeljko Reiner [Croatie] ; Marja-Riitta Taskinen [Finlande] ; Lale Tokgözoglu [Turquie] ; Anne Tybjaerg-Hansen [Danemark] ; Gerald F. Watts [Australie] | Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management |
| 001681 (2011) |
Jonathan Golledge [Australie] ; Ziad Mallat [France, Royaume-Uni] ; Alain Tedgui [France] ; Paul E. Norman [Australie] | Serum secreted phospholipase A2 is associated with abdominal aortic aneurysm presence but not progression |
| 001713 (2011) |
Paul J. W. H. Kappelle [Pays-Bas] ; Gilles Lambert [Australie, France] ; Björn Dahlb Ck [Suède, Pays-Bas] ; Lars Bo Nielsen [Danemark] ; Robin P. F. Dullaart [Suède, Pays-Bas] | Relationship of plasma apolipoprotein M with proprotein convertase subtilisin-kexin type 9 levels in non-diabetic subjects |
| 001783 (2011) |
Paul J. W. H. Kappelle [Pays-Bas] ; Gilles Lambert [Australie, France] ; Robin P. F. Dullaart [Pays-Bas] | Plasma proprotein convertase subtilisin-kexin type 9 does not change during 24 h insulin infusion in healthy subjects and type 2 diabetic patients |
| 001789 (2011) |
M. John Chapman [France] | Pitavastatin: Novel effects on lipid parameters |
| 001900 (2011) |
Michael R. Skilton [Australie] ; Jaye P. F. Chin-Dusting [Australie] ; Anthony M. Dart [Australie] ; Laima Brazionis [Australie] ; Olivier Lantieri [France] ; Kerin O'Dea [Australie] ; Beverley Balkau [Australie, France] | Metabolic health, obesity and 9-year incidence of peripheral arterial disease: The D.E.S.I.R. study |
| 001931 (2011) |
Fatiha Tabet [Australie] ; Gilles Lambert [Australie, France] ; Luisa F. Cuesta Torres [Australie] ; LIMING HOU [Australie] ; Irene Sotirchos [Australie] ; Rhian M. Touyz [Canada] ; Alicia J. Jenkins [Australie] ; Philip J. Barter [Australie] ; Kerry-Anne Rye [Australie] | Lipid-Free Apolipoprotein A-I and Discoidal Reconstituted High-Density Lipoproteins Differentially Inhibit Glucose-Induced Oxidative Stress in Human Macrophages |
| 001A12 (2011) |
YING ZHAO [Pays-Bas] ; Marieke Pennings [Pays-Bas] ; Carlos Lj. Vrins [Pays-Bas] ; Laura Calpe-Berdiel [Pays-Bas] ; Menno Hoekstra [Pays-Bas] ; J. Kar Kruijt [Pays-Bas] ; Roelof Ottenhoff [Pays-Bas] ; Reeni B. Hildebrand [Pays-Bas] ; Ronald Van Der Sluis [Pays-Bas] ; Wendy Jessup [Australie] ; Wilfried Le Goff [France] ; M. John Chapman [France] ; Thierry Huby [France] ; Albert K. Groen [Pays-Bas] ; Theo J. C. Van Berkel [Pays-Bas] ; Miranda Van Eck [Pays-Bas] | Hypocholesterolemia, foam cell accumulation, but no atherosclerosis in mice lacking ABC-transporter A1 and scavenger receptor BI |
